Clinical Trial Spotlight: Targeting Brain Mets in EGFR Lung Cancer Patients

Clinical Trial Spotlight: Targeting Brain Mets in EGFR Lung Cancer Patients

Desde: GRACEcast
0 0 hace 5 años
Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.

Síguenos en Facebook